CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid‑In Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022		123,170,172
Beginning balance at Dec. 31, 2022	$ 701,338	$ 123	$ 1,049,875	$ (39,951)	$ (308,709)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		367,171
Exercise of stock options	2,723		2,723
Vesting of restricted stock units (in shares)		370,146
Vesting of restricted stock units	1	$ 1
Stock-based compensation	19,550		19,550
Foreign currency translation adjustments	6,047			6,047
Net loss	(24,200)				(24,200)
Ending balance (in shares) at Mar. 31, 2023		123,907,489
Ending balance at Mar. 31, 2023	705,459	$ 124	1,072,148	(33,904)	(332,909)
Beginning balance (in shares) at Dec. 31, 2023		126,938,102
Beginning balance at Dec. 31, 2023	717,547	$ 126	1,162,993	(26,777)	(418,795)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		47,583
Exercise of stock options	280		280
Vesting of restricted stock units (in shares)		1,347,681
Stock-based compensation	20,579		20,579
Foreign currency translation adjustments	(1,812)			(1,812)
Net loss	(20,524)				(20,524)
Ending balance (in shares) at Mar. 31, 2024		128,333,366
Ending balance at Mar. 31, 2024	$ 716,070	$ 126	$ 1,183,852	$ (28,589)	$ (439,319)